{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:02:02Z","timestamp":1786982522777,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03841-0","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T12:55:09Z","timestamp":1762779309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pan-cancer multi-omics analysis reveals IQCE as a malignant cell-restricted oncogenic biomarker driving immunosuppression and chemoresistance in cutaneous melanoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Qing","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jielong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"3841_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.70008","author":"X Cen","year":"2025","unstructured":"Cen X, et al. Pan-cancer analysis shapes the Understanding of cancer biology and medicine. Cancer Commun (Lond). 2025. https:\/\/doi.org\/10.1002\/cac2.70008.","journal-title":"Cancer Commun (Lond)"},{"key":"3841_CR2","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.cell.2023.01.037","volume":"186","author":"S Loi","year":"2023","unstructured":"Loi S, et al. The next big questions in cancer research. Cell. 2023;186:1523\u20137. https:\/\/doi.org\/10.1016\/j.cell.2023.01.037.","journal-title":"Cell"},{"key":"3841_CR3","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","volume":"187","author":"C Swanton","year":"2024","unstructured":"Swanton C, et al. Embracing cancer complexity: hallmarks of systemic disease. Cell. 2024;187:1589\u2013616. https:\/\/doi.org\/10.1016\/j.cell.2024.02.009.","journal-title":"Cell"},{"key":"3841_CR4","doi-asserted-by":"publisher","unstructured":"Wang G et al. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis. Aging 16, 872\u2013910, https:\/\/doi.org\/10.18632\/aging.205426","DOI":"10.18632\/aging.205426"},{"key":"3841_CR5","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1002\/imt2.68","volume":"2","author":"C Wu","year":"2023","unstructured":"Wu C, et al. Pan-cancer analyses reveal molecular and clinical characteristics of Cuproptosis regulators. Imeta. 2023;2:e68. https:\/\/doi.org\/10.1002\/imt2.68.","journal-title":"Imeta"},{"key":"3841_CR6","doi-asserted-by":"publisher","unstructured":"Li Y et al. Pan-cancer proteogenomics connects oncogenic drivers to functional states. Cell 186, 3921\u20133944 e3925. https:\/\/doi.org\/10.1016\/j.cell.2023.07.014 (2023).","DOI":"10.1016\/j.cell.2023.07.014"},{"key":"3841_CR7","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1038\/s41467-024-49885-8","volume":"15","author":"A Coulton","year":"2024","unstructured":"Coulton A, et al. Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response. Nat Commun. 2024;15:5665. https:\/\/doi.org\/10.1038\/s41467-024-49885-8.","journal-title":"Nat Commun"},{"key":"3841_CR8","doi-asserted-by":"publisher","unstructured":"Chen H, et al. Unravelling infiltrating T-cell heterogeneity in kidney renal clear Ce Ll carcinoma: integrative single-cell and Spatial transcriptomic Profi Ling. J Cell Mol Med. 28;e18403. https:\/\/doi.org\/10.1111\/jcmm.18403.","DOI":"10.1111\/jcmm.18403"},{"key":"3841_CR9","doi-asserted-by":"publisher","unstructured":"He R et al. Advancing immunotherapy for melanoma: the critical role of single-cell analysis in identifying predictive biomarkers. Front Immunol 15, 1435187, https:\/\/doi.org\/10.3389\/fimmu.2024.1435187","DOI":"10.3389\/fimmu.2024.1435187"},{"key":"3841_CR10","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041555","author":"RJ DeBerardinis","year":"2024","unstructured":"DeBerardinis RJ, Vousden KH, Chandel NS. Cancer metabolism: aspirations for the coming decade. Cold Spring Harb Perspect Med. 2024. https:\/\/doi.org\/10.1101\/cshperspect.a041555.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3841_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.devcel.2014.01.021","volume":"28","author":"GV Pusapati","year":"2014","unstructured":"Pusapati GV, et al. EFCAB7 and IQCE regulate Hedgehog signaling by tethering the EVC-EVC2 complex to the base of primary cilia. Dev Cell. 2014;28:483\u201396. https:\/\/doi.org\/10.1016\/j.devcel.2014.01.021.","journal-title":"Dev Cell"},{"key":"3841_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/humu.23924","volume":"41","author":"A Estrada-Cuzcano","year":"2020","unstructured":"Estrada-Cuzcano A, et al. Novel IQCE variations confirm its role in postaxial polydactyly and cause ciliary defect phenotype in zebrafish. Hum Mutat. 2020;41:240\u201354. https:\/\/doi.org\/10.1002\/humu.23924.","journal-title":"Hum Mutat"},{"key":"3841_CR13","doi-asserted-by":"publisher","unstructured":"Currie D, et al. A potential prognostic gene signature associated with p53-Dependent NTRK1 activation and increased survival of neuroblastoma patients. Cancers (Basel). 2024;16. https:\/\/doi.org\/10.3390\/cancers16040722.","DOI":"10.3390\/cancers16040722"},{"key":"3841_CR14","doi-asserted-by":"publisher","unstructured":"Gao Y et al. Identification and Validation of Prognostically Relevant Gene Signature in Melanoma. Biomed Res Int. 2020, 5323614. https:\/\/doi.org\/10.1155\/2020\/5323614 (2020).","DOI":"10.1155\/2020\/5323614"},{"key":"3841_CR15","doi-asserted-by":"publisher","first-page":"622733","DOI":"10.3389\/pore.2021.622733","volume":"27","author":"S Lee","year":"2021","unstructured":"Lee S, Kim KM, Lee SY, Jung J. Estrogen aggravates tumor growth in a diffuse gastric cancer xenograft model. Pathol Oncol Res. 2021;27:622733. https:\/\/doi.org\/10.3389\/pore.2021.622733.","journal-title":"Pathol Oncol Res"},{"key":"3841_CR16","doi-asserted-by":"publisher","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The Sva package for removing batch effects and other unwanted variatio n in high-throughput experiments. Bioinf (Oxford England) 28, 882\u20133, https:\/\/doi.org\/10.1093\/bioinformatics\/bts034","DOI":"10.1093\/bioinformatics\/bts034"},{"key":"3841_CR17","doi-asserted-by":"publisher","unstructured":"Thul PJ, Lindskog C. The human protein atlas: A Spatial map of the human proteome. Protein Sci 27, 233\u201344, https:\/\/doi.org\/10.1002\/pro.3307","DOI":"10.1002\/pro.3307"},{"key":"3841_CR18","doi-asserted-by":"publisher","unstructured":"Cerami E et al. The cBio cancer genomics portal: an open platform for exploring multid imensional cancer genomics data. Cancer Discov 2, 401\u20134, https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095","DOI":"10.1158\/2159-8290.CD-12-0095"},{"key":"3841_CR19","doi-asserted-by":"publisher","unstructured":"Mayakonda A, Lin D-C, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28, 1747\u201356, https:\/\/doi.org\/10.1101\/gr.239244.118","DOI":"10.1101\/gr.239244.118"},{"key":"3841_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. https:\/\/doi.org\/10.1186\/1471-2105-12-77.","journal-title":"BMC Bioinformatics"},{"key":"3841_CR21","doi-asserted-by":"publisher","unstructured":"Liu CJ, et al. GSCA: an integrated platform for gene set cancer analysis at genomic, Pharmacogenomic and Immunogenomic levels. Brief Bioinform. 2023;24. https:\/\/doi.org\/10.1093\/bib\/bbac558.","DOI":"10.1093\/bib\/bbac558"},{"key":"3841_CR22","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"3841_CR23","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32:2847\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btw313.","journal-title":"Bioinformatics"},{"key":"3841_CR24","doi-asserted-by":"publisher","unstructured":"Li T et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48, W509\u201314, https:\/\/doi.org\/10.1093\/nar\/gkaa407","DOI":"10.1093\/nar\/gkaa407"},{"key":"3841_CR25","doi-asserted-by":"publisher","unstructured":"Thorsson V et al. The Immune Landscape of Cancer. Immunity 48, 812\u2013830 e814. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023 (2018).","DOI":"10.1016\/j.immuni.2018.03.023"},{"key":"3841_CR26","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han Y, et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 2023;51:D1425\u201331. https:\/\/doi.org\/10.1093\/nar\/gkac959.","journal-title":"Nucleic Acids Res"},{"key":"3841_CR27","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1158\/0008-5472.CAN-23-2650","volume":"84","author":"J Shi","year":"2024","unstructured":"Shi J, et al. The Web-Based portal SpatialTME integrates histological images with Single-Cell and Spatial transcriptomics to explore the tumor microenvironment. Cancer Res. 2024;84:1210\u201320. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2650.","journal-title":"Cancer Res"},{"key":"3841_CR28","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/s41467-023-36560-7","volume":"14","author":"Z Xun","year":"2023","unstructured":"Xun Z, et al. Reconstruction of the tumor Spatial microenvironment along the malignant-boundary-nonmalignant axis. Nat Commun. 2023;14:933. https:\/\/doi.org\/10.1038\/s41467-023-36560-7.","journal-title":"Nat Commun"},{"key":"3841_CR29","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1093\/bioinformatics\/btab003","volume":"37","author":"J Alquicira-Hernandez","year":"2021","unstructured":"Alquicira-Hernandez J, Powell JE. Nebulosa recovers single-cell gene expression signals by kernel density Estimation. Bioinformatics. 2021;37:2485\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/btab003.","journal-title":"Bioinformatics"},{"key":"3841_CR30","doi-asserted-by":"publisher","unstructured":"Meira-Machado L, Cadarso-Suarez C, Gude F, Araujo A. smoothHR: an R package for pointwise nonparametric estimation of hazard ratio curves of continuous predictors. Comput Math Methods Med 2013, 745742. https:\/\/doi.org\/10.1155\/2013\/745742 (2013).","DOI":"10.1155\/2013\/745742"},{"key":"3841_CR31","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/gb-2014-15-3-r47","volume":"15","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox NJ, Huang RS. Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. Genome Biol. 2014;15:R47. https:\/\/doi.org\/10.1186\/gb-2014-15-3-r47.","journal-title":"Genome Biol"},{"key":"3841_CR32","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9:e107468. https:\/\/doi.org\/10.1371\/journal.pone.0107468.","journal-title":"PLoS ONE"},{"key":"3841_CR33","doi-asserted-by":"publisher","unstructured":"Malta TM et al. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell 173, 338\u2013354 e315. https:\/\/doi.org\/10.1016\/j.cell.2018.03.034 (2018).","DOI":"10.1016\/j.cell.2018.03.034"},{"key":"3841_CR34","doi-asserted-by":"publisher","unstructured":"Yang C et al. A survey of optimal strategy for signature-based drug repositioning an d an application to liver cancer. eLife 11, https:\/\/doi.org\/10.7554\/elife.71880","DOI":"10.7554\/elife.71880"},{"key":"3841_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clindermatol.2008.09.001","volume":"27","author":"C Garbe","year":"2009","unstructured":"Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27:3\u20139. https:\/\/doi.org\/10.1016\/j.clindermatol.2008.09.001.","journal-title":"Clin Dermatol"},{"key":"3841_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-3-030-46227-7_6","volume":"1268","author":"U Leiter","year":"2020","unstructured":"Leiter U, Keim U, Garbe C. Epidemiology of skin cancer: update 2019. Adv Exp Med Biol. 2020;1268:123\u201339. https:\/\/doi.org\/10.1007\/978-3-030-46227-7_6.","journal-title":"Adv Exp Med Biol"},{"key":"3841_CR37","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41588-020-00739-1","volume":"52","author":"JR Conway","year":"2020","unstructured":"Conway JR, et al. Integrated molecular drivers coordinate biological and clinical States in melanoma. Nat Genet. 2020;52:1373\u201383. https:\/\/doi.org\/10.1038\/s41588-020-00739-1.","journal-title":"Nat Genet"},{"key":"3841_CR38","doi-asserted-by":"publisher","unstructured":"Cherepakhin OS, Argenyi ZB, Moshiri AS. Genomic and transcriptomic underpinnings of melanoma Genesis, Progression, and metastasis. Cancers (Basel). 2021;14. https:\/\/doi.org\/10.3390\/cancers14010123.","DOI":"10.3390\/cancers14010123"},{"key":"3841_CR39","doi-asserted-by":"publisher","first-page":"100796","DOI":"10.1016\/j.drup.2021.100796","volume":"59","author":"R Nussinov","year":"2021","unstructured":"Nussinov R, Tsai CJ, Jang H. Anticancer drug resistance: an update and perspective. Drug Resist Updat. 2021;59:100796. https:\/\/doi.org\/10.1016\/j.drup.2021.100796.","journal-title":"Drug Resist Updat"},{"key":"3841_CR40","doi-asserted-by":"publisher","first-page":"100646","DOI":"10.1016\/j.drup.2019.100646","volume":"47","author":"AB Sarmento-Ribeiro","year":"2019","unstructured":"Sarmento-Ribeiro AB, Scorilas A, Goncalves AC, Efferth T, Trougakos IP. The emergence of drug resistance to targeted cancer therapies: clinical evidence. Drug Resist Updat. 2019;47:100646. https:\/\/doi.org\/10.1016\/j.drup.2019.100646.","journal-title":"Drug Resist Updat"},{"key":"3841_CR41","doi-asserted-by":"publisher","unstructured":"Wen J et al. Genetic and transcriptional insights into immune checkpoint Blockade r esponse and survival: lessons from melanoma and beyond. J Transl Med 23, 467, https:\/\/doi.org\/10.1186\/s12967-025-06467-6","DOI":"10.1186\/s12967-025-06467-6"},{"key":"3841_CR42","doi-asserted-by":"publisher","unstructured":"Song B et al. Characterization of coagulation-related gene signature to predict prog Nosis and tumor immune microenvironment in skin cutaneous melanoma. Front Oncol 12, 975255, https:\/\/doi.org\/10.3389\/fonc.2022.975255","DOI":"10.3389\/fonc.2022.975255"},{"key":"3841_CR43","doi-asserted-by":"publisher","unstructured":"Wong SY, Reiter JF. The primary cilium at the crossroads of mammalian Hedgehog signaling. Curr Top Dev Biol 85, 225\u201360, https:\/\/doi.org\/10.1016\/S0070-2153(08)00809-0","DOI":"10.1016\/S0070-2153(08)00809-0"},{"key":"3841_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2046-2530-2-6","volume":"2","author":"SG Basten","year":"2013","unstructured":"Basten SG, Giles RH. Functional aspects of primary cilia in signaling, cell cycle and tumorigenesis. Cilia. 2013;2:6. https:\/\/doi.org\/10.1186\/2046-2530-2-6.","journal-title":"Cilia"},{"key":"3841_CR45","doi-asserted-by":"publisher","unstructured":"Carotenuto P, Gradilone SA, Franco B. Cilia and cancer: from molecular genetics to therapeutic strategies. Genes (Basel). 2023;14. https:\/\/doi.org\/10.3390\/genes14071428.","DOI":"10.3390\/genes14071428"},{"key":"3841_CR46","doi-asserted-by":"publisher","unstructured":"Gimotty PA et al. Identification of high-risk patients among those diagnosed with thin c utaneous melanomas. J Clin Oncology: Official J Am Societ Y Clin Oncol 25, 1129\u201334, https:\/\/doi.org\/10.1200\/JCO.2006.08.1463","DOI":"10.1200\/JCO.2006.08.1463"},{"key":"3841_CR47","doi-asserted-by":"publisher","unstructured":"Imperial R, Toor OM, Hussain A, Subramanian J, Masood A. Comprehensive Pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: its clinical implications. Sem Cancer Biol 54, 14\u201328, https:\/\/doi.org\/10.1016\/j.semcancer.2017.11.016","DOI":"10.1016\/j.semcancer.2017.11.016"},{"key":"3841_CR48","doi-asserted-by":"publisher","unstructured":"Regad T, Targeting. RTK signaling pathways in cancer. Cancers 7, 1758\u201384, https:\/\/doi.org\/10.3390\/cancers7030860","DOI":"10.3390\/cancers7030860"},{"key":"3841_CR49","doi-asserted-by":"publisher","unstructured":"Santarpia L, Lippman SM, El-Naggar AK. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets 16, 103\u201319, https:\/\/doi.org\/10.1517\/14728222.2011.645805","DOI":"10.1517\/14728222.2011.645805"},{"key":"3841_CR50","doi-asserted-by":"publisher","unstructured":"Bai X, Flaherty KT. Targeted and immunotherapies in BRAF mutant melanoma: where we stand a Nd what to expect. Br J Dermatol 185, 253\u201362, https:\/\/doi.org\/10.1111\/bjd.19394","DOI":"10.1111\/bjd.19394"},{"key":"3841_CR51","doi-asserted-by":"publisher","unstructured":"Ziogas DC, Konstantinou F, Bouros S, Theochari M, Gogas H. Combining BRAF\/MEK inhibitors with immunotherapy in the treatment of M etastatic melanoma. Am J Clin Dermatol 22, 301\u201314, https:\/\/doi.org\/10.1007\/s40257-021-00593-9","DOI":"10.1007\/s40257-021-00593-9"},{"key":"3841_CR52","doi-asserted-by":"publisher","unstructured":"Burmakin M, Shi Y, Hedstr\u00f6m E, Kogner P, Selivanova G. Dual targeting of Wild-Type and mutant p53 by small molecule RITA Resu Lts in the Inhibition of N-Myc and key survival oncogenes and kills Ne uroblastoma Cells\u2009<\u2009i\u2009>\u2009In Vivo\u2009and <\u2009i\u2009>\u2009In vitro. Clin Cancer Res 19, 5092\u2013103, https:\/\/doi.org\/10.1158\/1078-0432.ccr-12-2211","DOI":"10.1158\/1078-0432.ccr-12-2211"},{"key":"3841_CR53","doi-asserted-by":"publisher","unstructured":"Issaeva N et al. Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and act ivates p53 function in tumors. Nat Med 10, 1321\u20138, https:\/\/doi.org\/10.1038\/nm1146","DOI":"10.1038\/nm1146"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03841-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03841-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03841-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:10:01Z","timestamp":1762884601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03841-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3841"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03841-0","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"20 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2076"}}